150 324

Cited 27 times in

Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells.

Authors
Seo, DR; Kim, SY; Kim, KY; Lee, HG; Moon, JH; Lee, JS; Lee, SH; Kim, SU; Lee, YB
Citation
Experimental & molecular medicine, 40(1):19-26, 2008
Journal Title
Experimental & molecular medicine
ISSN
1226-36132092-6413
Abstract
Previously we demonstrated that ATP released from LPS-activated microglia induced IL-10 expression in a process involving P2 receptors, in an autocrine fashion. Therefore, in the present study we sought to determine which subtype of P2 receptor was responsible for the modulation of IL-10 expression in ATP-stimulated microglia. We found that the patterns of IL-10 production were dose-dependent (1, 10, 100, 1,000 microM) and bell-shaped. The concentrations of ATP, ATP-gammaS, ADP, and ADP-betaS that showed maximal IL-10 release were 100, 10, 100, and 100 microM respectively. The rank order of agonist potency for IL-10 production was 2'-3'-O-(4-benzoyl)-benzoyl ATP (BzATP)=dATP>2-methylthio-ADP (2-meSADP). On the other hand, 2-methylthio-ATP (2-meSATP), alpha,beta-methylene ATP (alpha,beta-meATP), UTP, and UDP did not induce the release of IL-10 from microglia. Further, we obtained evidence of crosstalk between P2 receptors, in a situation where intracellular Ca(2+) release and/or cAMP-activated PKA were the main contributors to extracellular ATP-(or ADP)-mediated IL-10 expression, and IL-10 production was down-regulated by either MRS2179 (a P2Y(1) antagonist) or 5'-AMPS (a P2Y(11) antagonist), indicating that both the P2Y(1) and P2Y(11) receptors are major receptors involved in IL-10 expression. In addition, we found that inhibition of IL-10 production by high concentrations of ATP-gammaS (100 microM) was restored by TNP-ATP (an antagonist of the P2X(1), P2X(3), and P2X(4) receptors), and that IL-10 production by 2-meSADP was restored by 2meSAMP (a P2Y(12) receptor antagonist) or pertussis toxin (PTX; a Gi protein inhibitor), indicating that the P2X(1), P2X(3), P2X(4)receptor group, or the P2Y(12) receptor, negatively modulate the P2Y(11) receptor or the P2Y(1) receptor, respectively.
MeSH terms
Adenosine Diphosphate/analogs & derivativesAdenosine Diphosphate/pharmacologyAdenosine Triphosphate/analogs & derivativesAdenosine Triphosphate/pharmacology*Adenylate Cyclase/antagonists & inhibitorsAnimalsCalcium/metabolismChelating Agents/pharmacologyCyclic AMP-Dependent Protein Kinases/antagonists & inhibitorsEnzyme Inhibitors/pharmacologyExtracellular Space/drug effectsExtracellular Space/metabolism*Gene Expression Regulation/drug effectsInterleukin-10/biosynthesis*Microglia/drug effects*Microglia/enzymologyMicroglia/metabolism*Purinergic P2 Receptor AgonistsPurinergic P2 Receptor AntagonistsRNA, Messenger/geneticsRNA, Messenger/metabolismRatsRats, Sprague-DawleyReceptor Cross-Talk/drug effects*Receptors, Purinergic P2/geneticsReceptors, Purinergic P2/metabolism*Thionucleotides/pharmacology
DOI
10.3858/emm.2008.40.1.19
PMID
18305394
Appears in Collections:
Journal Papers > Research Organization > Institute for Medical Sciences
AJOU Authors
이용범
Full Text Link
Files in This Item:
emm-40-19-26.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse